ZERBINI, MARIALUISA
 Distribuzione geografica
Continente #
NA - Nord America 5.886
AS - Asia 5.691
EU - Europa 4.832
AF - Africa 313
SA - Sud America 223
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 16.953
Nazione #
US - Stati Uniti d'America 5.832
CN - Cina 1.731
VN - Vietnam 1.434
SG - Singapore 1.421
GB - Regno Unito 1.299
DE - Germania 624
IT - Italia 597
UA - Ucraina 582
SE - Svezia 528
HK - Hong Kong 356
FR - Francia 315
IN - India 314
RU - Federazione Russa 281
IE - Irlanda 175
BR - Brasile 162
JP - Giappone 123
ZA - Sudafrica 101
KR - Corea 100
CH - Svizzera 89
EE - Estonia 84
TG - Togo 72
NL - Olanda 52
SC - Seychelles 49
FI - Finlandia 46
CI - Costa d'Avorio 45
BG - Bulgaria 42
BE - Belgio 35
CA - Canada 35
IR - Iran 32
NG - Nigeria 28
AR - Argentina 23
GR - Grecia 20
IQ - Iraq 19
BD - Bangladesh 17
PH - Filippine 17
AT - Austria 16
TH - Thailandia 15
UZ - Uzbekistan 15
ID - Indonesia 13
RO - Romania 12
EC - Ecuador 11
JO - Giordania 11
PK - Pakistan 11
PL - Polonia 10
SA - Arabia Saudita 10
TW - Taiwan 10
TR - Turchia 9
MX - Messico 8
LB - Libano 7
CO - Colombia 6
ES - Italia 6
MY - Malesia 6
PY - Paraguay 6
CL - Cile 5
EG - Egitto 5
AU - Australia 4
AZ - Azerbaigian 4
PE - Perù 4
AE - Emirati Arabi Uniti 3
DZ - Algeria 3
EU - Europa 3
IL - Israele 3
LT - Lituania 3
OM - Oman 3
SK - Slovacchia (Repubblica Slovacca) 3
UY - Uruguay 3
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
HN - Honduras 2
HU - Ungheria 2
KZ - Kazakistan 2
MA - Marocco 2
MD - Moldavia 2
NO - Norvegia 2
PR - Porto Rico 2
PS - Palestinian Territory 2
TN - Tunisia 2
VE - Venezuela 2
BO - Bolivia 1
CR - Costa Rica 1
CY - Cipro 1
DJ - Gibuti 1
DK - Danimarca 1
ET - Etiopia 1
GA - Gabon 1
JM - Giamaica 1
KE - Kenya 1
KH - Cambogia 1
LK - Sri Lanka 1
LV - Lettonia 1
NZ - Nuova Zelanda 1
PA - Panama 1
RS - Serbia 1
SI - Slovenia 1
SM - San Marino 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
TZ - Tanzania 1
ZM - Zambia 1
Totale 16.953
Città #
Southend 1.100
Singapore 900
Ashburn 595
Chandler 540
Fairfield 458
Dong Ket 448
Jacksonville 404
Hong Kong 339
Hefei 291
San Jose 281
Ho Chi Minh City 244
Wilmington 244
Ann Arbor 243
Seattle 240
Princeton 239
Woodbridge 232
Houston 221
Hanoi 196
Beijing 186
Dublin 171
Boardman 161
Cambridge 156
Tokyo 119
Padova 115
Westminster 115
Nanjing 110
Santa Clara 107
Lauterbourg 104
Berlin 85
Los Angeles 84
Seoul 82
Bern 78
Medford 73
Lomé 72
Buffalo 71
Milan 69
Mülheim 69
New York 64
Saint Petersburg 63
Shenyang 58
Jinan 52
Mahé 47
Abidjan 45
Helsinki 44
Shanghai 43
Sofia 42
Tianjin 42
Changsha 41
Bengaluru 38
Bologna 38
Guangzhou 37
Redwood City 37
Haiphong 36
Nanchang 36
Brussels 35
Dallas 35
Hebei 31
Zhengzhou 31
Florence 28
Abeokuta 27
Da Nang 26
Hangzhou 25
San Diego 25
Verona 25
Bremen 24
Des Moines 23
Frankfurt am Main 22
Jiaxing 22
Paris 19
Olalla 18
Taizhou 18
Toronto 18
San Venanzo 17
Norwalk 16
Shijiazhuang 15
Ningbo 14
São Paulo 14
Wuhan 14
Phoenix 13
Shenzhen 13
Taiyuan 13
The Dalles 13
Yubileyny 13
Haikou 12
Redondo Beach 12
Amman 11
Biên Hòa 11
Falkenstein 11
Falls Church 11
Kuban 11
London 11
Pune 11
Curitiba 10
Mountain View 10
Rio de Janeiro 10
Rome 10
Turin 10
Vienna 10
Ardabil 9
Chengdu 9
Totale 10.791
Nome #
Infezione da Parvovirus B19 nella donna in gravidanza, nel feto e nel neonato. 245
A new primer set improves the efficiency of competitive PCR-ELISA for the detection of B19 DNA 237
Presence of high-risk mucosal human papillomavirus genotypes in primary melanoma and in acquired dysplastic melanocytic naevi 222
Comparison of Abbott RealTime High Risk HPV and Hybrid Capture 2 for the detection of high-risk HPV DNA in a referral population setting 210
Parvovirus B19 in pregnancy: possible consequences of vertical transmission. 209
Parvovirus in gravidanza: possibili conseguenze della trasmissione verticale 202
Antibody response to B19 parvovirus VP1 and VP2 linear epitopes in patients with haemophilic arthritis 200
Assessment of the presence of mucosal human papillomaviruses in malignant melanomas using combined fluorescent in situ hybridization and chemiluminescent immunohistochemistry 198
Molecular testing for detection of in vitro infectivity of plasma pools contaminated with B19 virus 197
Analysis of Parvovirus B19 DNA methylation status in experimental and natural infections. 197
Presence and type of oncogenic human papillomavirus in classic and in differentiated vulvar intraepithelial neoplasia and keratinizing vulvar squamous cell carcinoma 196
Analisi dell’integrazione del DNA di HPV16 in campioni cervicali, mediante PCR qualitativa e quantitativa 194
Analysis by real-time PCR of B19 virus replication and expression patterns in primary bone marrow and myeloblastoid cell lines 192
High-throughput polymerase chain reaction chemiluminescent enzyme immunoassay for typing and quantifying human papillomavirus DNAs 191
Ricerca e determinazione del carico virale di parvovirus B19 mediante tecnica di Real-time PCR calibrata 186
Carica virale, integrazione ed espressione degli oncogeni di HPV16: implicazioni nella progressione della patologia cervicale 186
Sviluppo di un saggio di Real- Time PCR per la quantificazione del DNA di HPV in campioni citologici cervicali 184
Analysis of HPV16 E6*I-II transcripts in cervical samples 184
Efficient treatment of paraffin-embedded cervical tissue for HPV DNA testing by HC-II and PCR assays 183
A proteomic approach to the analysis of B19 capsid proteins 183
Comparative evaluation of an automated assay for parvovirus B19 antibody detection 180
Determination of physical status and viral load of HPV 16 DNA in cytological cervical samples by quantitative PCR assays 179
Gestational and fetal outcomes in B19 maternal infection: a problem of diagnosis 177
Disruption of HPV 16 E1 and E2 genes in precancerous cervical lesions 175
Analisi della competenza funzionale di cloni genomici di parvovirus B19 175
Presenza e ruolo della metilazione dei dinucleotidi CpG nel DNA di parvovirus B19. 175
Ricerca del parvovirus B19 nello screening per la sicurezza degli emoderivati 172
Recurrent erythema in patients with long-term parvovirus B19 infection 172
Analysis of E6* spliced products of HPV16 as molecular markers of cervical disease progression. 171
Analisi della competenza funzionale di cloni genomici di parvovirus B19 per lo sviluppo di vettori virali 171
Inter-laboratory comparison of qualitative and quantitative detection of hepatitis C(HCV) virus RNA in diagnostic virology: a multicentre study (MS) in Italy 169
Diagnosis of fetal parvovirus B19 infection: value of virological assays in fetal specimens. 164
Parvovirus B19 infection during pregnancy and evaluation of fetal outcomes 163
Correlazione tra presenza del DNA di HPV ed espressione della P16INK4A in lesioni benigne e maligne della vulva 162
Rivelazione e caratterizzazione di varianti genotipiche di parvovirus B19 in sangue proveniente da unità trasfusionale 161
Application of the NASBA method for the detection of human papillomavirus E6-E7 transcripts in patients treated for high grade CIN and positive to HPV16 161
Parvovirus B19-derived fetal complications following gestational infection. 161
Peptide nucleic acid-based in situ hybridization assay for detection of parvovirus B19 nucleic acids 160
Presence and type of oncogenic human papillomavirus in classic VIN, differentiated VIN and keratinizing VSCC 159
Analysis of the functional competence of genomic clones of Parvovirus B19 159
Expression of bioactive recombinant bovine interferon-gamma using baculovirus 158
Lo studio PATER: Population-Based Frequency Assessment of HPV Infections in Borderline Pap Tests in the Emilia-Romagna Region 156
Analisi di trascritti virali di HPV16 come indicatori di carcinoma cervicale in situ 155
B19 in vitro infection of permissive systems: a quantitative analysis of virus replication and expression 155
Chemiluminescent assay for p16INK4A quantitation in cervical biopsies combined with fluorescent HPV DNA in situ hybridisation 154
Analisi funzionale del genoma di parvovirus B19 in due sistemi sperimentali: infezione in vitro e trasfezione con cloni ricombinanti 154
Espressione e purificazione di gamma-interferon bovino bioattivo in baculovirus 153
Analisi del DNA di HPV 16 e degli mRNA E6/E7 in campioni citologici cervicali 153
Analysis of splice junctions and polyadenylation sites of parvovirus B19 genome by a PCR-based approach 152
Evidence of human bocavirus viremia in healthy blood donors. 151
Follow up of patients treated of HPV 16 high-grade CIN: HPV DNA patterns and disease implication 150
Calibrated real-time PCR for evaluation of parvovirus b19 viral load 150
Diagnosi virologica di infezione da papillomavirus umani 148
Evaluation of quantitative PCR assays for the determination of physical status and viral load of HPV16 DNA 148
Functional analysis and quantitative determination of the expression profile of human parvovirus B19 148
Chemiluminescent quantitative immunohistochemical p16 INK4A localization as a marker for cervical intraepithelial neoplasias 148
Parvovirus B19 DNA Is Commonly Harboured in Human Skin. 148
HPV DNA patterns and disease implications in the follow-up of patients treated for HPV16 high-grade carcinoma in situ 148
Competitive PCR-ELISA protocols for the quantitative and the standardized detection of viral genomes. 147
Carica virale, integrazione ed espressione degli oncogeni di HPV16: implicazioni nella progressione della patologia cervicale 147
Sviluppo di un saggio di spettrometria di massa, ad elevata processività, per la ricerca e genotipizzazione di 12 HPV ad alto rischio oncogeno 147
Population-based frequency assessment of HPV-induced lesions in patients with borderline Pap tests in the Emilia-Romagna Region: the PATER study. 146
Human papillomavirus in melanoma: reply from authors 144
Factors predicting the outcome of conservately trated adenocarcinoma in situ of uterine cervix: an analysis of 166 cases 143
High-throughput type-specific detection of HPV using MassARRAY technology 142
Comparison of abbott realtime HPV assay and digene HC2 HPV DNA test for the detection of high-risk HPV DNA in a referral population setting Source: JOURNAL OF CLINICAL VIROLOGY Volume: 46 Pages: S49-S49 Supplement: Suppl. 1 Published: SEP 2009 141
Parvovirus B19 genome as a single, two-state replicative and transcriptional unit 141
Qualitative PCR-ELISA protocol for the detection and typing of viral genomes. 140
Analisi di trascritti virali di HPV16 come indicatori di carcinoma cervicali in situ 140
Correlazione tra presenza di HPV, carica e integrazione virale in lesioni (pre)neoplastiche vulvari 139
Parvovirus B19 in pregnancy: possible consequence of vertical transmission 138
Correlation of high-risk human papillomavirus genotypes persistence and risk of residual or recurrent cervical disease after surgical treatment 136
High-throughput two-step LNA real time PCR assay for the quantitative detection and genotyping of HPV prognostic-risk groups. 136
Implicazioni nella progressione della patologia cervicale 135
Seroprevalence of IgG against conformational and linear capsid antigens of parvovirus B19 in Italian blood donors 132
Prevention of iatrogenic transmission of B19 infection: different approaches to detect, remove or inactivate virus contamination 128
HepG2 hepatocellular carcinoma cells are a non-permissive system for B19 virus infection. 128
PNA-Based in situ hybridisation assay for the detection and quantification of parvovirus B19 nucleic acids 127
Meningoencephalitis with persistent parvovirus B19 infection in an apparently healthy woman 127
Viral DNA load, physical status and E2/E6 ratio as markers to grade HPV16 positive women for high-grade cervical lesions 127
Metodo di real time PCR in due step per la definizione di gruppi di rischio di HPV e per la quantificazione genotipo specifica 126
Quantitative evaluation of HBoV DNA in serum samples from Italian population. 126
La biologia molecolare nella diagnosi delle infezioni da HPV 125
B19 parvovirus infections: diagnostic technologies 125
Functional analysis of B19 virus genome by transcript-specific quantitative real-time PCR 125
Valutazione della persistenza di diversi genotipi di HPV nel follow-up di pazienti trattate per lesioni cervicali di alto gradi 125
Detection of HPV 16 E6-E7 transcripts in cervical cytological samples and correlation with HPV-DNA physical status 123
Colorimetric and chemiluminescent Peptide Nucleic Acid-based in situ hybridisation assay for the detection and quantification of parvovirus B19 nucleic acids 123
Valutazione della correlazione tra presenza di HPV ed espressione della P16 INK4A in lesioni vulvari e cervicali mediante FISH combinata ad IHC con rivelazione chemiluminescente 121
Molecular analysis of HPV 16 E6I/E6II spliced mRNAs and correlation with the viral physical state and the grade of the cervical lesion. 121
Valutazione del rischio di insorgenza di nefropatia associata a polyomavirus nello screening di trapiantati renali 121
Detection of parvovirus B19 IgG: choice of antigens and serological tests 118
Studio dell’espressione di parvovirus B19 in sistemi permissivi e non mediante real-time PCR 115
Persistent parvovirus B19 infection resulting in carpal tunnel syndrome 114
Clonazione, espressione e purificazione di g-IFN bovino ricombinante in baculovirus 112
Nuovo saggio FISH per la ricerca del DNA di HPV combinato ad IHC chemiluminescente per la quantificazione di p16 INK4A in lesioni cervicali 107
Ricerca di HPV ad alto rischio oncogeno: Abbott Real Time HPV Assay e Digene HC2 HPV DNA Test a confronto 107
PNA-based probe for quantitative chemiluminescent in situ hybridisation imaging of cellular parvovirus B19 replication kinetics 105
Investigation on the presence of B19 virus prototype and variant genotypes in a population of italian blood donors 103
Construction and functional analysis of B19 genomic clones 103
Totale 15.467
Categoria #
all - tutte 44.400
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.400


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021934 0 0 0 0 0 0 0 0 0 97 105 732
2021/20222.085 140 105 142 226 177 107 25 112 62 215 358 416
2022/20232.233 251 328 120 269 159 140 61 124 349 36 225 171
2023/2024807 38 96 40 131 47 161 114 70 19 34 17 40
2024/20251.975 73 333 211 134 278 104 221 52 17 61 52 439
2025/20264.265 337 594 495 420 581 298 333 128 833 246 0 0
Totale 17.241